Stanford study description
Open this page in the complete interactive Atlas
Stanford describes participant eligibility, the comparison groups and the study’s focus on OCD symptoms.
Where this source fits
MDMA · Obsessive-compulsive disorder
A Stanford study asks whether MDMA-assisted cognitive behavioral therapy improves obsessive-compulsive symptoms, measured using the Yale-Brown Obsessive Compulsive Scale. The active comparison uses methamphetamine with CBT.
The target enrollment is 40. The reviewed registry record lists recruiting and has no posted results.
Reading basis · Original source summarized in the experimental-drug section
Original source
https://clinicaltrials.stanford.edu/trials/m/NCT05783817.html